Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Safety and Feasibility Trial of Ultrasonic Debris Clearance to Promote Brain Resilience
Authors not listed
Stanford University · 2026
Abstract
This pilot study will evaluate the safety, tolerability, and feasibility of Ultrasonic Debris Clearance (UDC), a noninvasive low-intensity focused ultrasound intervention, in amyloid-positive adults who are asymptomatic but at risk for Alzheimer's disease, or who have mild cognitive impairment or mild dementia. The study is designed to test whether repeated UDC sessions can be delivered safely and feasibly in this population, while also exploring efficacy via biomarkers and clinical measures.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2026). Safety and Feasibility Trial of Ultrasonic Debris Clearance to Promote Brain Resilience. <em>Stanford University</em>. https://clinicaltrials.gov/study/NCT07573982
Vancouver
Anonymous. Safety and Feasibility Trial of Ultrasonic Debris Clearance to Promote Brain Resilience. Stanford University. 2026.
BibTeX
@misc{anon2026Safety,
title = {Safety and Feasibility Trial of Ultrasonic Debris Clearance to Promote Brain Resilience},
author = {Anonymous},
journal = {Stanford University},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomed Industries, Inc. 2018
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of NA-831 in Alzheimer Patients With Mild Cognitive Impairment
Merck Sharp & Dohme LLC 2006
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of MK0249 for the Symptomatic Treatment of Alzheimer's Disease
Washington University School of Medicine 2012
Open access · US-GOV
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Massachusetts General Hospital 2019
Open access · US-GOV
Mental Training for Adults With Mild Cognitive Impairment
University of California, San Diego 2023
Open access · US-GOV
Interventions to Promote Brain Health Virtual Reality Study
Alpha Cognition, Inc 2026
Open access · US-GOV